Hughes GRV.Lupus patients are protected from cancer. (Editorial)Lupus2001; 10: 833-834 .
2.
Cibere J , Sibley J , Haga M.Systemic lupus erythematosus and the risk of malignancy . Lupus2001; 10: 394-400 .
3.
Ramsey-Goldman R , Clarke AE.Double trouble: are lupus and malignancy associated? (Editorial.)Lupus2001; 10: 388-391 .
4.
Sultan SM , Ioannou Y , Isenberg DA.Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review . Rheumatology (Oxford)2000; 10: 1147-1152 .
5.
Sweeney DM , Manzi S , Janosky Jet al.Risk of malignancy in women with systemic lupus erythematosus . J Rheumatol1995; 22: 1478-1482 .
6.
Xu Y , Wiernik PH.Systemic lupus erythematosus and B-cell hematologic neoplasm . Lupus2001; 10: 841-850 .
7.
Nived O , Bengtsson A , Jonsen A , Sturfelt G , Olsson H.Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden . Lupus2001; 10: 500-504 .
8.
Tomer Y , Sherer Y , Shoenfeld Y.Autoantibodies, autoimmunity and cancer . (Review.) Oncol Rep1998; 5: 753-761 .
Abu-Shakra M , Buskila D , Ehrenfeld M , Conrad K , Shoenfeld Y.Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies . Ann Rheum Dis2001; 60: 433-441 .
11.
Tramonti G , Ferdeghini M , Donadio Cet al.Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia . Cancer Detect Prev2000; 24: 86-90 .
12.
Malamitsi-Puchner A , Vazeou-Gerasimidi A , Sarandakou A , Taiotis J , Trikka P , Bartsocas C.Tissue polypeptide-specific antigen serum concentrations in children, adolescents, and young adults with type 1 diabetes . (Letter.) Diabetes Care2002; 25: 240-241 .
13.
Rydlander L , Ziegler E , Bergman Tet al.Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18 . Eur J Biochem1996; 241: 309-314 .
14.
Kassanos D , Batsis D , Rizos Det al.Tissue polypeptide specific antigen (TPS) throughout normal pregnancy . Anticancer Res2000; 20: 129-131 .
15.
Hrycek A , Cieślik P , Tustanowski J , Nowak S , Jedynak P.Selected serum cytokines in systemic lupus erythematosus treated with quinagolide . Lupus2001; 10: 424-430 .
16.
Tan EM , Cohen AS , Fries JFet al.The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum1982; 25: 1271-1277 .
17.
Jimena P , Aguirre MA , Lopez-Curbelo A , de Andres M , Garcia-Courtay C , Cuadrado MJ.Prolactin levels in patients with systemic lupus erythematosus: a case controlled study . Lupus1998; 7: 383-386 .
18.
Jara LJ , Lavalle C , Espinoza LR.Does prolactin have a role in the pathogenesis of systemic lupus erythematosus ? J Rheumatol1992; 19: 1333-1336 .